CURR News and Press, Cure Pharmaceutical Holding Corp From 05/20/19

OXNARD, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced the addition of four key hires to their growing leadership team. Michael Redard will serve as CURE’s Chief Financial Officer. Jos...

STATnews reports that the rapidly growing cannabidiol (CBD) industry, expected to balloon to over $1.3B in three years, is creating headaches for lawmakers and the FDA. More news on: GW Pharmaceuticals plc, ETFMG Alternative Harvest ETF, Global X Fertilizers/Potash ETF, Healthcare stocks...

OXNARD, Calif., May 14, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, today announced that it has closed on the previously announced acquisition of Chemistry Holdings Inc. (“Chemistry Hold...

CHICAGO, May 02, 2019 (GLOBE NEWSWIRE) -- Today, at the CPhI Conference, Meroven LLC announced a five-year agreement with CURE Pharmaceutical Corporation (OTCQB: CURR) to exclusively market and distribute Spee-D ® , a weekly dose oral thin film Vitamin D3 in the USA. Under the t...

OXNARD, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, today announced that it has extended the close of the previously announced acquisition of Chemistry Holdings Inc. (“Ch...

LAS VEGAS, April 30, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will be presenting at the Planet MicroCap Showcase at 8:30 a.m. on Wednesday, May 1, 2019 and CEO Rob Davidson will conduct one-on-...

OXNARD, Calif., April 26, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, has been named 2019’s Innovative Business of the Year by Oxnard Chamber of Commerce in recognition to the company’...

PHOENIX, AZ / ACCESSWIRE / April 16, 2019 / Uptick Newswire Stock Day Podcast welcomed CURE Pharmaceutical (OTCQB: CURR) (''the Company''), a vertically integrated drug delivery and development company committed to improving drug efficacy, safety and the patient experience through its prop...

LOS ANGELES, April 09, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced a global healthcare awareness initiative with United Smart Cities for the purpose of educating, informing and providing the next generati...

CURE Pharmaceutical ( OTCQB:CURR -10.2% ) announced the acquisition of Chemistry Holdings Inc., a formulation technology company that is developing innovative delivery systems for a variety of industries, in an all-stock transaction. More news on: CURE Pharmaceutical Holding Corp., Mer...